CARDIOVAX, LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 20116
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19236
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0100,432 ANTIGEN SPECIFIC TOLEROGENIC ANTIGEN PRESENTING CELLS AND RELATED USES COMPOSITIONS, METHODS AND SYSTEMSNov 15, 16Apr 13, 17[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9221876 Methods for treating kidney disease with fragments of ApoB-100Nov 06, 12Dec 29, 15[A61K, A61P, C07K]
9205139 Immunomodulatory methods and systems for treatment and/or prevention of aneurysmsNov 11, 11Dec 08, 15[A61K, C07K]
9205141 Immunomodulatory methods and systems for treatment and/or prevention of hypertensionNov 11, 11Dec 08, 15[A61K, C12N, C07K]
9125850 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosisNov 12, 10Sep 08, 15[A61K, G01N]
8647628 Peptide epitopes of apolipoprotein BJan 08, 13Feb 11, 14[A61K, C07K]
8642043 Peptide epitopes of apolipoprotein BJan 08, 13Feb 04, 14[A61K, C07K]
8642726 Peptide epitopes of apolipoprotein BJan 08, 13Feb 04, 14[C07K]
8609605 T cell response to APOB100Mar 17, 10Dec 17, 13[A61K, A61P, C07K]
8506964 Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosisFeb 04, 11Aug 13, 13[A61K, C12P, C07K]
8470768 Peptide epitopes of apolipoprotein BJan 08, 13Jun 25, 13[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0037,672 FUSION PROTEINS COMPRISING ANTIGENIC APOB-100 PROTEIN FRAGMENTS AND A PROTEIN CARRIER, RELATED COMPOSITIONS, METHODS AND SYSTEMS FOR TREATMENT AND/OR PREVENTION OF ATHEROSCLEROSISAbandonedAug 05, 13Feb 06, 14[C07K]
2013/0189,292 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositionsAbandonedSep 22, 11Jul 25, 13[A61K]
2012/0251,513 Antigen Specific Tolerogenic Antigen Presenting Cells and Related Uses Compositions, Methods and SystemsAbandonedSep 17, 10Oct 04, 12[A61K, C12N, A61P]
2010/0279,325 USE OF MODIFIED EXTRACELLULAR MATRIX PROTEINS IN DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSISAbandonedJun 11, 10Nov 04, 10[G01N, C07K]
2010/0183,706 PEPTIDE EPITOPES OF APOLIPOPROTEIN BAbandonedDec 22, 09Jul 22, 10[A61K, A61P, C07K]
2009/0226,475 PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSISAbandonedFeb 27, 09Sep 10, 09[A61K, G01N, C07K]
2009/0117,137 PEPTIDE EPITOPES OF APOLIPOPROTEIN BAbandonedOct 31, 07May 07, 09[A61K, A61P]
2009/0092,618 PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSISAbandonedOct 31, 08Apr 09, 09[A61K, A61P]
2008/0070,265 PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSISAbandonedOct 19, 07Mar 20, 08[C12Q, G01N]
2007/0104,725 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosisAbandonedSep 19, 06May 10, 07[A61K, G01N]
2004/0002,111 Atherosclerosis vaccineAbandonedDec 19, 02Jan 01, 04[A61K, G01N, C07K]
2003/0105,003 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoproteinAbandonedApr 04, 02Jun 05, 03[A61K, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.